Details of the Drug

General Information of Drug (ID: DMNAT25)

Drug Name

ADC-1013

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT02379741) ADC-1013 First-in-Human Study. U.S. National Institutes of Health.